Lifecore Biomedical

Yahoo Finance • 4 days ago

Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR)

Laughing Water Capital, an investment management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Class A investment in Laughing Water Capital returned approximately -4.5% net of al... Full story

Yahoo Finance • last month

Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer

-- Site Transfer Agreement for the Manufacture of Commercially Marketed Product -- -- Second Agreement Supports the Expansion of Product Commercially Manufactured at Lifecore to a New Delivery System -- -- Fourth Commercial Site Transfer... Full story

Yahoo Finance • 2 months ago

Lifecore Biomedical Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, March 16, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Lifecore Biomedical, Inc. The investigation focuses on Lifecore Biomedical executive officers and whether inve... Full story

Yahoo Finance • 2 months ago

Lifecore Biomedical Q4 Earnings Call Highlights

Lifecore Biomedical logo Key Points Revenue and profitability improved: Q4 revenue rose to $35.7M (up 10%) and seven-month transition revenue was $75.5M (up 20%), while gross margin climbed to 31% and adjusted EBITDA increased to $8.6M f... Full story

Yahoo Finance • 2 months ago

Lifecore Biomedical GAAP EPS of -$0.16, revenue of $35.75M

* Lifecore Biomedical press release [https://seekingalpha.com/pr/20438291-lifecore-biomedical-reports-financial-results-for-the-fourth-quarter-and-transition-period] (LFCR [https://seekingalpha.com/symbol/LFCR]): Q4 GAAP EPS of -$0.16.... Full story

Yahoo Finance • 2 months ago

Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag

Information technology, industrials and utilities are set to feature prominently in this week’s earnings calendar, with 249 companies scheduled to report. This week’s quant rankings highlight strong momentum among technology and industria... Full story

Yahoo Finance • 2 months ago

Lifecore Biomedical to Participate at DCAT Week 2026

CHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will pa... Full story

Yahoo Finance • 4 months ago

Important Notice to Long-Term Shareholders of CarMax, Inc. (NYSE: KMX); Inspire Medical Systems, Inc. (NYSE: INSP); Integer Holdings Corp. (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, Dec. 31, 2025 (GLOBE NEWSWIRE) -- CarMax, Inc. (NYSE: KMX): Grabar Law Office is investigating claims on behalf of shareholders of CarMax, Inc. (NYSE: KMX). The investigation concerns whether certain officers and director... Full story

Yahoo Finance • 4 months ago

Lifecore Biomedical to be Added to Nasdaq Biotech Index

Lifecore Biomedical, Inc. CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has... Full story

Yahoo Finance • 4 months ago

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer 

Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product Partner’s Program Size Positions it to Become a Top Five Commercial Customer for Lifecore CHASKA,... Full story

Yahoo Finance • 6 months ago

Here’s the Analysis of LifeCore’s (LFCR) Growth Potential

Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund returned approximately -9%, bringing the YTD returns to... Full story

Yahoo Finance • 6 months ago

Lifecore outlines $74M–$76M revenue target for transition period while advancing commercial wins and margin expansion

Earnings Call Insights: Lifecore Biomedical, Inc. (LFCR) Q3 2025 MANAGEMENT VIEW * CEO Paul Josephs highlighted, "Lifecore is a differentiated injectable CDMO with a strong foundation in high-grade hyaluronic acid that has served as ou... Full story

Yahoo Finance • 6 months ago

Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025

CHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial result... Full story

Yahoo Finance • 6 months ago

Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3

Laughing Water Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter of 2025, Laughing Water Capital declined approximately -1% net of... Full story

Yahoo Finance • 6 months ago

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major Multinational Organization in Recent Months Separa... Full story

Yahoo Finance • 6 months ago

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, I... Full story

Yahoo Finance • 7 months ago

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

CHASKA, Minn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at... Full story

Yahoo Finance • 7 months ago

Stocks Supported by AI Spending Boom

The S&P 500 Index ($SPX) (SPY) today is up +0.40%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.84%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.07%.  December E-mini S&P futures (ESZ25) are up +0.37%, and December E-mini Nas... Full story

Yahoo Finance • 7 months ago

Stocks Climb on Rampant AI Optimism

The S&P 500 Index ($SPX) (SPY) today is up +0.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.45%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.18%.  December E-mini S&P futures (ESZ25) are up +0.27%, and December E-mini Nas... Full story

Yahoo Finance • 7 months ago

LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeCore (LFCR) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in LifeCore between October 7, 2... Full story